TC Biopharm (Holdings) Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for TCBP stock has a target of 3.00, which predicts an increase of 354.55% from the current stock price of 0.66.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$3.00	$3.00	$3.00	$3.00
Change	+354.55%	+354.55%	+354.55%	+354.55%

Analyst Ratings

According to 1 stock analyst, the rating for TCBP is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Aug '24	Sep '24	Oct '24	Nov '24	Dec '24
Strong Buy	1	1	1	1	1
Buy	0	0	0	0	0
Hold	0	0	0	0	0
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	1	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $7 → $3	Strong Buy	Maintains	$7 → $3	+354.55%	Dec 6, 2024
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $18,000 → $14,000	Strong Buy	Maintains	$18,000 → $14,000	+2,121,112.12%	Apr 27, 2023
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $18,000	Strong Buy	Initiates	$18,000	+2,727,172.73%	Jan 26, 2023
Constantine Davides EF Hutton	EF Hutton	Strong Buy Initiates $500,000	Strong Buy	Initiates	$500,000	+75,757,475.76%	Mar 28, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

n/a

from -191.21

EPS Next Year

n/a

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023
Revenue	3.43M	1.98M	1.98M	3.84M	-
Revenue Growth	-	-42.26%	-	94.30%	-
EPS	-	-	-	-	-191.21
EPS Growth	-	-	-	-	-
Forward PE	-	-	-	-	-
No. Analysts	-	-	-	-	-

Financial currency is GBP. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue
High
Avg
Low

Revenue Growth

Revenue Growth
High
Avg
Low

EPS Forecast

EPS
High
Avg
Low

EPS Growth

EPS Growth
High
Avg
Low

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.